Stock Code: 300381 stock abbreviation: Guangdong Vtr Bio-Tech Co.Ltd(300381)
Bond Code: 123018 bond abbreviation: profit convertible bond Announcement No.: 2022-007 Guangdong Vtr Bio-Tech Co.Ltd(300381)
With regard to the announcement that the shares of directors and senior managers have not been reduced at the expiration of the share reduction plan, the company and all members of the board of directors guarantee that the content of information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.
Guangdong Vtr Bio-Tech Co.Ltd(300381) (hereinafter referred to as “the company”) disclosed the pre disclosure announcement on the reduction of shares held by directors and senior managers (Announcement No.: 2021-072) on July 1, 2021. Mr. Zhou Derong, the director, vice president and Secretary of the board of directors of the company, plans to reduce his holdings of no more than 307125 shares of the company (no more than 0.06% of the total share capital of the company) by block trading or centralized bidding within six months after the 15 trading days from the date of the pre disclosure announcement; Mr. Feng Guohua, vice president, plans to reduce his holdings of no more than 95900 shares (no more than 0.02% of the total share capital of the company) by means of centralized bidding within six months after 15 trading days from the date of the pre disclosure announcement; Mr. Li Zhu, vice president and chief financial officer, plans to reduce his holdings of no more than 307125 shares of the company (no more than 0.06% of the total share capital of the company) in the form of block trading or centralized bidding within six months after 15 trading days from the date of the pre disclosure announcement; Mr. Du Hongfang, vice president, plans to reduce his holding of no more than 170100 shares of the company (no more than 0.03% of the total share capital of the company) by means of centralized bidding within six months after 15 trading days from the date of the pre disclosure announcement.
As of the disclosure date of this announcement, upon the expiration of the reduction plan, in accordance with the provisions on the reduction of shares held by shareholders, directors, supervisors and senior managers of listed companies and the implementation rules for the reduction of shares held by shareholders, directors, supervisors and senior managers of listed companies of Shenzhen stock exchange, the relevant implementation is hereby announced as follows:
1、 Implementation progress of share reduction plan
As of the disclosure date of this announcement, upon the expiration of the share reduction plan, the above directors and senior managers have not reduced their shares of the company during the period of the share reduction plan.
2、 Other relevant instructions
1. The reduction plan does not violate the provisions of Several Provisions on the reduction of shares held by shareholders, directors, supervisors and senior managers of listed companies, the implementation rules for the reduction of shares held by shareholders, directors, supervisors and senior managers of listed companies of Shenzhen Stock Exchange and other relevant laws, regulations and normative documents.
2. As of the date of this announcement, the period of this share reduction plan has expired and this share reduction plan has ended.
It is hereby announced.
Guangdong Vtr Bio-Tech Co.Ltd(300381) board of directors
January 23, 2022
